Abivax raises €46.2m for product development

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
ABBs-Block Trades

Abivax raises €46.2m for product development

Aidan Gregory
September 02, 2022 02:05 PM
The Paris skyline and Eiffel Tower, France

The French company has completed a sale of new shares despite the selloff of biotech stocks

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

ABBs-Block TradesFrance
AG
Aidan Gregory
Gift this article